Skip to main content
. 2014 Jun;58(6):3151–3156. doi: 10.1128/AAC.02411-14

TABLE 3.

MICs for 40 M. genitalium strains with isolation histories and presence of mutations

Strain ID (reference)a Sample collection yr Country MIC (μg/ml)b
Mutationc
AZM ERY SOL CIP MXF DOX 23S rRNA rpl4 rpl22
G37 (1) 1980 United Kingdom 0.008 0.125 0.002 8 0.125 0.5 WT WT WT
M30 (1, 29) 1980 United Kingdom 0.008 0.125 ≤0.001 8 0.125 0.5 WT WT WT
M2288 (46) 1991 Denmark 0.002 0.125 ≤0.001 0.5 0.125 0.063 WT N172S, A114V, A116V WT
M2282 (46) 1991 Denmark 0.004 0.063 ≤0.001 4 0.125 0.25 WT WT WT
M2300 (46) 1991 Denmark 0.008 0.125 ≤0.001 16 0.125 0.25 WT WT WT
M2321 (46) 1991 Denmark 0.004 0.063 ≤0.001 8 0.25 0.5 WT WT WT
M2341 (46) 1991 Denmark 0.008 0.25 ≤0.001 2 0.25 1 WT WT WT
M6090d (29) 1994 France 0.004 0.063 ≤0.001 2 0.063 0.125 WT WT WT
M6151d (29) 1994 France 0.008 0.125 ≤0.001 4 0.125 0.25 WT WT WT
M6312d (30) 1994 France 0.004 0.063 ≤0.001 8 0.125 0.25 WT WT WT
M6285 (47) 1997 Sweden 0.004 0.125 ≤0.001 1 0.125 0.5 WT WT WT
M6280 (47) 1997 Sweden 0.004 0.063 ≤0.001 1 0.063 0.125 WT N172S WT
M6328 (47) 1998 Sweden 0.004 0.125 ≤0.001 2 0.125 0.25 WT N21K A43V
M6281 (47) 2001 Sweden 0.008 0.063 ≤0.001 0.5 0.125 0.25 WT WT WT
M6286 (47) 2001 Sweden 0.002 0.03 ≤0.001 2 0.03 0.25 WT A114S, R45K WT
M6287 (47) 2003 Japan 0.002 0.03 ≤0.001 4 2 0.125 WT P81S WT
M6284 (47) 2003 Japan 0.004 0.125 ≤0.001 4 0.125 0.25 WT WT WT
M6283 (47) 2003 Japan 0.004 0.063 ≤0.001 2 0.125 0.5 WT WT WT
M6282 (47) 2003 Japan 0.008 0.125 ≤0.001 1 0.125 0.25 WT WT WT
M6311 2004 Sweden 0.004 0.125 ≤0.001 1 0.063 0.5 WT WT WT
M6327 (22) 2005 Denmark 0.016 0.125 0.002 8 0.25 0.25 WT WT WT
M6375 2005 Sweden 0.004 0.063 ≤0.001 1 0.03 0.125 WT WT WT
M6315 2005 Sweden 0.002 0.063 ≤0.001 1 0.125 0.5 WT WT WT
M6475 2006 Sweden 0.008 0.125 ≤0.001 1 0.5 0.5 WT WT WT
M6713 2010 Australia 0.063 0.03 ≤0.001 0.5 0.125 0.5 WT P81S WT
M6303 (22) 2003 Norway >8 >16 0.5 8 0.25 2 A2059G H69R WT
M6270 (22) 2004 Australia >8 >16 0.5 4 0.125 0.25 A2059G WT E123K
M6320 (22) 2004 Australia ≥64 ≥64 0.25 0.5 0.063 0.25 A2059G WT WT
M6489 2007 Sweden >16 >16 1 >16 >16 1 A2059G H69R WT
M6593 2008 Norway 16 >16 0.5 2 0.125 0.063 A2059G WT WT
M6735 2010 Norway >16 ≥64 0.5 16 8 1 A2059G H69R WT
M6712 2010 Australia >16 ≥64 0.5 >16 8 1 A2059G H69R S81N
M6711 2010 Australia >16 ≥64 0.25 >16 8 1 A2059G WT WT
M6271 (22) 2004 Australia >8 >32 0.5 4 0.125 0.25 A2058G WT WT
M6257 (22) 2004 Sweden >8 > 16 2 1 0.25 0.5 A2058G WT WT
M6321 (22) 2004 Australia ≥64 ≥64 1 2 0.03 0.125 A2058G WT WT
M6604 2009 Denmark 64 >16 2 4 0.25 0.5 A2058G WT WT
M6714 2010 Norway >16 ≥64 4 16 4 1 A2058G WT WT
M6302 (22) 2004 Sweden >8 >16 16 8 0.25 0.125 A2058C WT WT
M6848 2008 United States >16 ≥64 4 ND ND ND A2058C WT WT
a

Strains without a reference have not been described previously.

b

AZM, azithromycin; ERY, erythromycin; SOL, solithromycin; CIP, ciprofloxacin; MXF, moxifloxacin; DOX, doxycycline; ND, not determined.

c

Macrolide resistance-mediating mutations in the 23S rRNA gene (E. coli numbering) and mutations in the genes encoding the ribosomal proteins L4 and L22 (M. genitalium numbering). WT, wild-type sequence of the gene.

d

M6090, M6151, and M6312 are consecutive isolates from the same patient.